CTOs on the Move

Satsuma Pharmaceuticals

www.satsumarx.com

 
Satsuma Pharmaceuticals is focused on developing best-in-class products to address the unmet needs of migraine sufferers.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.satsumarx.com
  • 395 Oyster Point Boulevard Suite 300
    South San Francisco, CA USA 94080
  • Phone: N/A

Executives

Name Title Contact Details

Funding

Satsuma Pharmaceuticals raised $62M on 04/24/2019
Satsuma Pharmaceuticals raised $80M on 03/01/2021

Similar Companies

Eddingpharm Group Co.

Eddingpharm Group Co. is a Carrboro, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PCI Synthesis

PCI Synthesis is a custom chemical manufacturer of new chemical entities (NCEs), generic APIs, and other specialty chemical products.

Tenami Pharmaceuticals Inc

Tenami Pharmaceuticals Inc is a Sacramento, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Stern at Home Therapy

Stern At Home Therapy is transforming how outpatient therapy is experienced.

Virpax Pharmaceuticals

Virpax`s lead product candidate, Probudur, is being developed using our proprietary liposomal encapsulation to deliver a sustain release of local anesthetic at the wound/incision site to control post-operative pain for 96 hours. We have executed Cooperative Research and Development Agreements (CRADA), as well as the National Institute of Health/NCATS; U.S. Army Institute of Surgical Research/Department of Defense to develop differentiated non-addictive treatment options and the Epilepsy Therapy Screening Program (ETSP) which is focused on focused on addressing drug resistant epilepsy, disease prevention and modification. The three products in development are targeting unmet global needs in three separate multi-billion-dollar markets, including rare diseases. Our proprietary drug-delivery-platforms have been developed to optimize the efficacy of nonaddictive medications to manage Post Operative Pain, Severe Pain, Post Cancer Pain, PTSD, and Rare Pediatric Epilepsy including Lennox-Gastaut Syndrome (LGS) and Dravet Syndrome (Orphan Diseases)